Mohamed Hebbar
AuthID: R-00F-GS5
1
TITLE: Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil, and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228).
AUTHORS: Francis Levi; Valerie Boige; Mohamed Hebbar; Denis Smith; Celine Lepere; Focan, CNJ; Rosine Guimbaud; Carlos Carvalho; Salvatore Tumolo; Pasquale F Innominato; Yves Ajavon; Stephanie Truant; Denis Castaing; Thierry De Baere; Francis Kunstlinger; Abdoulaye Karaboue; Mohamed Bouchahda; Philippe R Rougier; Rene Adam; Michel Ducreux;
PUBLISHED: 2013, SOURCE: Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, ISSUE: 4
AUTHORS: Francis Levi; Valerie Boige; Mohamed Hebbar; Denis Smith; Celine Lepere; Focan, CNJ; Rosine Guimbaud; Carlos Carvalho; Salvatore Tumolo; Pasquale F Innominato; Yves Ajavon; Stephanie Truant; Denis Castaing; Thierry De Baere; Francis Kunstlinger; Abdoulaye Karaboue; Mohamed Bouchahda; Philippe R Rougier; Rene Adam; Michel Ducreux;
PUBLISHED: 2013, SOURCE: Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, ISSUE: 4
INDEXED IN: 
WOS
WOS2
TITLE: Hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil, and oxaliplatin plus intravenous cetuximab (Cet) (Optiliv) after failure on one versus two or three chemotherapy protocols in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) (European phase II clinical trial NCT00852228).
AUTHORS: Michel Ducreux; Pasquale F Innominato; Mohamed Hebbar; Denis Michel Smith; Celine Lepere; Focan, CNJ; Rosine Guimbaud; Carlos Carvalho; Salvatore Tumolo; Sameh Awad; Stephanie Truant; Denis Castaing; Abdoulaye Karaboue; Thierry De Baere; Francis Kunstlinger; Mohamed Bouchahda; Valerie Boige; Philippe Rougier; Rene Adam; Francis Levi;
PUBLISHED: 2013, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, ISSUE: 15
AUTHORS: Michel Ducreux; Pasquale F Innominato; Mohamed Hebbar; Denis Michel Smith; Celine Lepere; Focan, CNJ; Rosine Guimbaud; Carlos Carvalho; Salvatore Tumolo; Sameh Awad; Stephanie Truant; Denis Castaing; Abdoulaye Karaboue; Thierry De Baere; Francis Kunstlinger; Mohamed Bouchahda; Valerie Boige; Philippe Rougier; Rene Adam; Francis Levi;
PUBLISHED: 2013, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, ISSUE: 15
INDEXED IN: WOS
WOS3
TITLE: First European phase II trial of intravenous (iv) cetuximab (Cet) and hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil and oxaliplatin in patients with unresectable liver metastases from wt KRAS colorectal cancer (CRC) after systemic therapy failure (OPTILIV, NCT00852228)
AUTHORS: Francis Levi; Michel Ducreux; Mohamed Hebbar; Philippe Rougier; Focan, CNJ; Rosine Guimbaud; Carlos Carvalho; Salvatore Tumolo; Pasquale F Innominato; Yves Ajavon; Denis Castaing; Thierry De Baere; Abdoulaye Karaboue; Celine Lepere; Valerie Boige; Laetitia Proux; Rene Adam; Mohamed Bouchahda;
PUBLISHED: 2012, SOURCE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, ISSUE: 15
AUTHORS: Francis Levi; Michel Ducreux; Mohamed Hebbar; Philippe Rougier; Focan, CNJ; Rosine Guimbaud; Carlos Carvalho; Salvatore Tumolo; Pasquale F Innominato; Yves Ajavon; Denis Castaing; Thierry De Baere; Abdoulaye Karaboue; Celine Lepere; Valerie Boige; Laetitia Proux; Rene Adam; Mohamed Bouchahda;
PUBLISHED: 2012, SOURCE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, ISSUE: 15
INDEXED IN: WOS
WOS